Published: 09 April, 2018 | Volume 2 - Issue 1 | Pages: 001-016
Figure 5:
5: Structure of anti-Alzheimer’s drugs in phase III clinical trials representing different mechanisms of action.
Read Full Article HTML DOI: 10.29328/journal.aac.1001010 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."